Insmed Incorporated INSM
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 72.89% | 95.88% | 36.25% | -39.46% | -67.79% |
| Total Depreciation and Amortization | 127.13% | 47.10% | 71.55% | 127.78% | 58.25% |
| Total Amortization of Deferred Charges | 5.40% | -8.55% | -14.50% | -12.57% | -5.30% |
| Total Other Non-Cash Items | -61.77% | -157.75% | -103.71% | 1,666.19% | 158.35% |
| Change in Net Operating Assets | -75.01% | -361.39% | 2.84% | -233.86% | 188.34% |
| Cash from Operations | 83.41% | 56.79% | 15.01% | -26.34% | -21.47% |
| Capital Expenditure | -132.63% | -79.65% | 65.44% | -144.96% | 34.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 82.89% | -86.70% | 197.30% | 193.08% | 24.00% |
| Cash from Investing | 82.20% | -89.24% | 230.20% | 195.55% | 24.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -12.85% | 69.34% | -13.17% | -13.12% | -13.53% |
| Issuance of Common Stock | -28.33% | -96.75% | 2.05% | 152.29% | -91.41% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -29.25% | -96.83% | 1.78% | -78.75% | -91.59% |
| Foreign Exchange rate Adjustments | 127.56% | -128.56% | -161.79% | 100.47% | -153.07% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.39% | -104.25% | 147.27% | 87.74% | -20.91% |